Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial (Q28244429)
scientific article (publication date: 21 June 2006)
Language:
(P31) (Q13442814)
(P50) (Q39977580)
(Q47700105)
(Q7906022)
(Q57838486)
(Q28112995)
(P304) 2727-41
2727
(P407) (Q1860)
(P433) 23
(P478) 295
(P577) Wednesday, June 21, 2006
(P921) (Q412178)
(Q128581)
(P1433) (Q1470970)
(P1476) "Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial" (language: en)
"Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial" (language: en)
(P2093) Joseph P Costantino
D Lawrence Wickerham
Walter M Cronin
James N Atkins
Therese B Bevers
Louis Fehrenbacher
Eduardo R Pajon
James L Wade
André Robidoux
Richard G Margolese
Joan James
Carolyn D Runowicz
Worta McCaskill-Stevens
Leslie G Ford
Norman Wolmark
Victor G. Vogel
other details
aliases Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes<SUBTITLE>The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial</SUBTITLE>
description scientific article (publication date: 21 June 2006)

External Links